EP3283648A4 - Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues - Google Patents
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues Download PDFInfo
- Publication number
- EP3283648A4 EP3283648A4 EP16780637.1A EP16780637A EP3283648A4 EP 3283648 A4 EP3283648 A4 EP 3283648A4 EP 16780637 A EP16780637 A EP 16780637A EP 3283648 A4 EP3283648 A4 EP 3283648A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- microbiome
- therapeutics
- health issues
- neurological health
- derived diagnostics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 230000000926 neurological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/002—Electrode membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/301—Anxiety or phobic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/304—Mood disorders, e.g. bipolar, depression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/305—Attention deficit disorder; Hyperactivity
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Databases & Information Systems (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Data Mining & Analysis (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Bioethics (AREA)
- Artificial Intelligence (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562146833P | 2015-04-13 | 2015-04-13 | |
| US201562146852P | 2015-04-13 | 2015-04-13 | |
| US201562146810P | 2015-04-13 | 2015-04-13 | |
| US201562147337P | 2015-04-14 | 2015-04-14 | |
| US201562147058P | 2015-04-14 | 2015-04-14 | |
| US201562147077P | 2015-04-14 | 2015-04-14 | |
| US201562147315P | 2015-04-14 | 2015-04-14 | |
| US201562147124P | 2015-04-14 | 2015-04-14 | |
| PCT/US2016/027312 WO2016168316A1 (en) | 2015-04-13 | 2016-04-13 | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3283648A1 EP3283648A1 (en) | 2018-02-21 |
| EP3283648A4 true EP3283648A4 (en) | 2019-03-20 |
Family
ID=57126241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP16780637.1A Pending EP3283648A4 (en) | 2015-04-13 | 2016-04-13 | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3283648A4 (en) |
| CN (1) | CN107709576B (en) |
| AU (1) | AU2016248050A1 (en) |
| WO (1) | WO2016168316A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3687375A4 (en) * | 2016-11-21 | 2022-01-19 | Psomagen, Inc. | Method and system for characterizing a headache-related condition |
| KR101944660B1 (en) * | 2018-01-29 | 2019-01-31 | 주식회사 엠디헬스케어 | Method for diagnosis of depression using analysis of bacteria metagenome |
| CN109785915B (en) * | 2018-12-24 | 2021-03-19 | 东软集团股份有限公司 | Data collection method, device, storage medium and electronic equipment |
| CN109697718A (en) * | 2018-12-25 | 2019-04-30 | 电子科技大学 | A kind of self-closing disease detection method and device based on graph theory |
| KR20210150502A (en) * | 2019-04-10 | 2021-12-10 | 젠팅 타우알엑스 다이어그노스틱 센터 에스디엔 비에이치디 | Adaptive neurological examination method |
| CN111429977B (en) * | 2019-09-05 | 2024-02-13 | 中国海洋大学 | Novel molecular similarity search algorithm based on attention of graph structure |
| CN111370116A (en) * | 2020-03-18 | 2020-07-03 | 浙江大学 | Intestinal microbial marker for predicting curative effect of bipolar affective disorder and screening application thereof |
| CN114334003B (en) * | 2021-12-22 | 2023-03-17 | 中国水产科学研究院南海水产研究所 | Fermented golden pomfret deep learning quality discrimination method and system based on single molecule sequencing |
| CN115998773A (en) * | 2022-09-19 | 2023-04-25 | 重庆医科大学 | Application of bifidobacterium pseudolongum in preparation of medicine for treating attention deficit hyperactivity disorder |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120252775A1 (en) * | 2010-05-26 | 2012-10-04 | Sydney Martin Finegold | Method for diagnosing, preventing, and treating neurological diseases |
| US20130121968A1 (en) * | 2011-10-03 | 2013-05-16 | Atossa Genetics, Inc. | Methods of combining metagenome and the metatranscriptome in multiplex profiles |
| WO2015013214A2 (en) * | 2013-07-21 | 2015-01-29 | Whole Biome, Inc. | Methods and systems for microbiome characterization, monitoring and treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2310532B1 (en) * | 2008-06-30 | 2014-05-07 | The Washington University | Methods of promoting weight loss and associated arrays |
| NZ618935A (en) * | 2010-08-04 | 2014-03-28 | Karma Medical Prod Co Ltd | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
| WO2013008102A2 (en) * | 2011-07-14 | 2013-01-17 | R.E.D. Laboratories N.V../ S.A. | Methods and compositions for evaluating and/or treating chronic immune diseases |
| CN114949001A (en) * | 2012-08-29 | 2022-08-30 | 加州理工学院 | Diagnosis and treatment of autism spectrum disorders |
| US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
-
2016
- 2016-04-13 AU AU2016248050A patent/AU2016248050A1/en not_active Abandoned
- 2016-04-13 WO PCT/US2016/027312 patent/WO2016168316A1/en active Application Filing
- 2016-04-13 EP EP16780637.1A patent/EP3283648A4/en active Pending
- 2016-04-13 CN CN201680028238.2A patent/CN107709576B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120252775A1 (en) * | 2010-05-26 | 2012-10-04 | Sydney Martin Finegold | Method for diagnosing, preventing, and treating neurological diseases |
| US20130121968A1 (en) * | 2011-10-03 | 2013-05-16 | Atossa Genetics, Inc. | Methods of combining metagenome and the metatranscriptome in multiplex profiles |
| WO2015013214A2 (en) * | 2013-07-21 | 2015-01-29 | Whole Biome, Inc. | Methods and systems for microbiome characterization, monitoring and treatment |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016248050A1 (en) | 2017-11-09 |
| CN107709576B (en) | 2022-06-03 |
| CN107709576A (en) | 2018-02-16 |
| EP3283648A1 (en) | 2018-02-21 |
| WO2016168316A1 (en) | 2016-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3347496A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for oral health | |
| EP3347495A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health | |
| EP3209803A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics | |
| EP3397150A4 (en) | System and methods for neurological monitoring and assisted diagnosis | |
| EP3218074A4 (en) | System and method for providing an alternate reality ride experience | |
| EP3221340C0 (en) | Diagnostic method employing human neutrophil lipocalin (hnl) | |
| EP3283648A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues | |
| EP3223263A4 (en) | Catheter simulator and imaging method for catheter simulator | |
| EP3161465A4 (en) | System and method for sensing oil quality | |
| EP3347367A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis | |
| EP3346912A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health | |
| EP3283086A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features | |
| EP3346910A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for eczema | |
| SG11201700739QA (en) | System and method for modular ride vehicles | |
| EP3117231A4 (en) | System and method for low-field, multi-channel imaging | |
| EP3299918A4 (en) | Abnormality diagnosis system and abnormality diagnosis method | |
| EP3229093A4 (en) | Abnormality diagnosis method and abnormality diagnosis system | |
| EP3096605A4 (en) | Quenched granular absorbent and system and method for making quenched granular absorbent | |
| EP3105965A4 (en) | System and method for connection rehoming | |
| EP3283084A4 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | |
| EP3111700A4 (en) | System and method for ue-specific offloading | |
| EP3340804A4 (en) | System and method for sensing oil quality | |
| EP3120162A4 (en) | System and method for performing transformer diagnostics | |
| EP3335380A4 (en) | Method and system for transaction diagnostics | |
| EP3355778A4 (en) | System and method for optimizing body and object interactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20171020 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 35/74 20150101ALI20181109BHEP Ipc: C12Q 1/68 20180101ALI20181109BHEP Ipc: C12Q 1/689 20180101ALI20181109BHEP Ipc: C12Q 1/6883 20180101ALI20181109BHEP Ipc: G06F 19/24 20110101ALI20181109BHEP Ipc: G06F 19/18 20110101AFI20181109BHEP |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20190218 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 35/74 20150101ALI20190306BHEP Ipc: C12Q 1/68 20180101AFI20190306BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20190918 |
|
| 19U | Interruption of proceedings before grant |
Effective date: 20191011 |
|
| 19W | Proceedings resumed before grant after interruption of proceedings |
Effective date: 20201201 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| D18D | Application deemed to be withdrawn (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PSOMAGEN, INC. |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20231107 |